76 related articles for article (PubMed ID: 15208687)
21. Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformation.
Konishi H; Karakas B; Abukhdeir AM; Lauring J; Gustin JP; Garay JP; Konishi Y; Gallmeier E; Bachman KE; Park BH
Cancer Res; 2007 Sep; 67(18):8460-7. PubMed ID: 17875684
[TBL] [Abstract][Full Text] [Related]
22. Expression of the tumor suppressor ARHI inhibits the growth of pancreatic cancer cells by inducing G1 cell cycle arrest.
Lu X; Qian J; Yu Y; Yang H; Li J
Oncol Rep; 2009 Sep; 22(3):635-40. PubMed ID: 19639215
[TBL] [Abstract][Full Text] [Related]
23. Induction of p21(WAF1/CIP1) by human synovial sarcoma-associated chimeric oncoprotein SYT-SSX1.
Tsuda M; Watanabe T; Seki T; Kimura T; Sawa H; Minami A; Akagi T; Isobe K; Nagashima K; Tanaka S
Oncogene; 2005 Dec; 24(54):7984-90. PubMed ID: 16103879
[TBL] [Abstract][Full Text] [Related]
24. Differential oncogenic potential of activated RAS isoforms in melanocytes.
Whitwam T; Vanbrocklin MW; Russo ME; Haak PT; Bilgili D; Resau JH; Koo HM; Holmen SL
Oncogene; 2007 Jul; 26(31):4563-70. PubMed ID: 17297468
[TBL] [Abstract][Full Text] [Related]
25. The farnesyltransferase inhibitor, LB42708, inhibits growth and induces apoptosis irreversibly in H-ras and K-ras-transformed rat intestinal epithelial cells.
Kim HS; Kim JW; Gang J; Wen J; Koh SS; Koh JS; Chung HH; Song SY
Toxicol Appl Pharmacol; 2006 Sep; 215(3):317-29. PubMed ID: 16712893
[TBL] [Abstract][Full Text] [Related]
26. [The role of different kinase pathways of signal transduction in proliferation of E1A + Ras transformants].
Abramova MV; Svetlikova SB; Grinkevich VV; Pospelov VA
Tsitologiia; 2005; 47(12):1071-81. PubMed ID: 16706195
[TBL] [Abstract][Full Text] [Related]
27. Involvement of H- and N-Ras isoforms in transforming growth factor-beta1-induced proliferation and in collagen and fibronectin synthesis.
Martínez-Salgado C; Fuentes-Calvo I; García-Cenador B; Santos E; López-Novoa JM
Exp Cell Res; 2006 Jul; 312(11):2093-106. PubMed ID: 16624289
[TBL] [Abstract][Full Text] [Related]
28. p53 is preferentially recruited to the promoters of growth arrest genes p21 and GADD45 during replicative senescence of normal human fibroblasts.
Jackson JG; Pereira-Smith OM
Cancer Res; 2006 Sep; 66(17):8356-60. PubMed ID: 16951143
[TBL] [Abstract][Full Text] [Related]
29. An immunohistochemical study of p16(INK4a) expression in multistep thyroid tumourigenesis.
Ball E; Bond J; Franc B; Demicco C; Wynford-Thomas D
Eur J Cancer; 2007 Jan; 43(1):194-201. PubMed ID: 17046239
[TBL] [Abstract][Full Text] [Related]
30. Epidermal growth factor receptor-mediated proliferation of enterocytes requires p21waf1/cip1 expression.
Sheng G; Bernabe KQ; Guo J; Warner BW
Gastroenterology; 2006 Jul; 131(1):153-64. PubMed ID: 16831599
[TBL] [Abstract][Full Text] [Related]
31. Ras and Myc can drive oncogenic cell proliferation through individual D-cyclins.
Yu Q; Ciemerych MA; Sicinski P
Oncogene; 2005 Oct; 24(47):7114-9. PubMed ID: 16103884
[TBL] [Abstract][Full Text] [Related]
32. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
Qian J; Niu J; Li M; Chiao PJ; Tsao MS
Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
[TBL] [Abstract][Full Text] [Related]
33. Retinoblastoma pathway defects show differential ability to activate the constitutive DNA damage response in human tumorigenesis.
Tort F; Bartkova J; Sehested M; Orntoft T; Lukas J; Bartek J
Cancer Res; 2006 Nov; 66(21):10258-63. PubMed ID: 17079443
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of the Ras oncoprotein reduces proliferation of hepatocytes in vitro and in vivo in rats.
da Silva Morais A; Saliez A; Leclercq I; Horsmans Y; Stärkel P
Clin Sci (Lond); 2008 Jan; 114(1):73-83. PubMed ID: 17678500
[TBL] [Abstract][Full Text] [Related]
35. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
Park H; Lee YJ; Kim TH; Lee J; Yoon S; Choi WS; Myung CS; Kim HS
Int J Mol Med; 2008 Nov; 22(5):605-11. PubMed ID: 18949380
[TBL] [Abstract][Full Text] [Related]
36. Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells.
Greco S; Muscella A; Elia MG; Romano S; Storelli C; Marsigliante S
J Cell Physiol; 2004 Oct; 201(1):84-96. PubMed ID: 15281091
[TBL] [Abstract][Full Text] [Related]
37. The ability of E1A to rescue ras-induced premature senescence and confer transformation relies on inactivation of both p300/CBP and Rb family proteins.
Deng Q; Li Y; Tedesco D; Liao R; Fuhrmann G; Sun P
Cancer Res; 2005 Sep; 65(18):8298-307. PubMed ID: 16166306
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of cytokinesis and akt phosphorylation by chaetoglobosin K in ras-transformed epithelial cells.
Matesic DF; Villio KN; Folse SL; Garcia EL; Cutler SJ; Cutler HG
Cancer Chemother Pharmacol; 2006 Jun; 57(6):741-54. PubMed ID: 16254733
[TBL] [Abstract][Full Text] [Related]
39. Functional analysis of CDK inhibitor p21WAF1.
Fotedar R; Bendjennat M; Fotedar A
Methods Mol Biol; 2004; 281():55-71. PubMed ID: 15220521
[TBL] [Abstract][Full Text] [Related]
40. Immortalized fibroblasts from NF-kappaB RelA knockout mice show phenotypic heterogeneity and maintain increased sensitivity to tumor necrosis factor alpha after transformation by v-Ras.
Gapuzan ME; Schmah O; Pollock AD; Hoffmann A; Gilmore TD
Oncogene; 2005 Sep; 24(43):6574-83. PubMed ID: 16027734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
